Cassini is collaborating with the Kentucky College of Optometry (KYCO) to provide the next generation of optometrists with the most innovative corneal analysis available.

Using the Cassini Corneal Shape Analyzer, KYCO, which is located at the at the University of Pikeville, becomes the first optometry school to include the Cassini in their education program.

The agreement is aimed at improving education and research in key critical areas of optometry including astigmatism, corneal pathologies, dry eye and surgical co-management.

The company uses patented multi-colored LED point-to-point ray tracing to provide a GPS-like analysis of the cornea including axial and elevation maps used for cataract planning, contact lens fitting and diagnosing corneal pathologies.

“At Kentucky College of Optometry, we have put a premium on the technology offered to our students and patients,” said Assistant Professor at KYCO, George Asimellis, PhD.

Asimellis, an anterior-segment imaging expert, has been working with the Cassini since the prototype device. He has published 6 papers in the peer review literature on this subject matter, 2 , 3 , 4 , 5 , 6 and presented the Cassini in various international conferences including ARVO, AAO, ASCRS and ESCRS.

“For any corneal refractive procedure to be successful, it requires a comprehensive and thorough imaging of the cornea. Anterior and posterior astigmatism can affect the results. This is what we’ll be teaching our students. Cassini is uniquely positioned among other anterior imaging devices to provide perhaps the most accurate estimate of total corneal astigmatism magnitude and axis”, he added.

When Cassini was launched in 2013, it demonstrated the ability to accurately provide anterior corneal steep axis repeatability of less than three degrees.

The capability has led many of the top ophthalmic practices in the United States and International markets to choose Cassini as their preferred corneal diagnostic device for refractive-cataract surgery planning.

Cassini’s Total Corneal Astigmatism functionality uses patented second purkinje reflection-based analysis of the posterior cornea.

The company’s posterior and anterior data is calculated to provide surgeons with the total corneal power, as well as, steep axis and magnitude of astigmatism. The impact of this information benefits patients undergoing cataract surgery with individual measurements of the Total Corneal Astigmatism (TCA) rather than using a generic nomogram.

Cassini provides the personalized data that enables cataract surgeons to create a unique, personalized surgical plan for each patient individually – without ignoring the posterior corneal astigmatism.

“This is a very exciting collaboration for Cassini, which to this date has focused mainly on the cataract market,” said Jeroen Cammeraat, CEO of Cassini. “Our patented technology platform allows us to expand applications to improve the quality of eye care and having an influential partner such as Kentucky College of Optometry certainly will aide our research and development.”

To view a case analysis CLICK HERE

About Cassini
Cassini pioneers smart eye diagnosis solutions that are affordable, fast and user-friendly for care providers worldwide to serve their patients best.

Cassini Total Corneal Astigmatism helps cataract surgeons to better understand corneal properties in order to improve outcomes and improve refractive outcomes. Cassini offers a full suite of examinations required for toric and multifocal IOL implantation, including corneal topography, posterior corneal curvature, mesopic and photopic pupillometry and full color photography.

Cassini employs red, green and yellow LEDs that are each positioned in a unique relationship to four of its neighbors, giving each one a ’gps-like’ coordinate. Cassini uses the ray-tracing principle to measure the relative position of each point, using the three different colors for ‘triangulation.’

www.cassinitca.com

For more information please contact
Jeroen Cammeraat, CEO, +31 70 399 31 12 j.cammeraat@i-optics.com or
James O’Connor, Director of Clinical Marketing, +1 610-500-0053 j.oconnor@i-optics.com

NO COMMENTS